The Cyrus Poonawala Group, owner of world’s largest vaccine manufacturer Serum Institute of India, has sold its Czech Republic-based Praha Vaccines to Novavax for $167 million, helping the US biotechnology firm...
Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop...
Regeneron to buy back $5 billion stake held by Sanofi
U.S. drugmaker Regeneron Pharmaceuticals said on Monday it would repurchase about $5 billion of its shares directly from France’s Sanofi, without altering their over-a-decade-long partnership. Sanofi, which owns some 23...
South Korea’s Samsung Biologics signs $231 million supply deal with GSK
South Korean contract drugs manufacturer Samsung Biologics Co Ltd said on Friday it had signed a deal worth more than $231 million with GlaxoSmithKline PLC (GSK) to supply biopharmaceutical products over the next eight...
Cipla’s board approves Rs3,000 crore fundraising proposal
Indian pharmaceuticals major Cipla Ltd on Friday said that its board had approved a proposal to raise up to Rs3,000 crore through sale of equity shares or equity linked instruments, the company said in a stock exchange...
Jubilant Life Science inks pact with Gilead to make remdesivir
Jubilant Life Sciences Ltd on Tuesday announced that its subsidiary Jubilant Generics Ltd has entered into a non-exclusive licencing agreement with US-based Gilead Sciences Inc to manufacture and sell the potential...
Ratan Tata picks up stake in 18-year old’s pharma startup
Ratan Tata, chairman emeritus at Tata Sons, on Thursday invested an undisclosed amount in a pharmaceutical start-up Generic Aadhaar, in his personal capacity. The startup is run by 18-year-old Arjun Deshpande, who is...
CVC Capital set to buy into Cancer chain HCG, to be co-promoter
CVC Capital is expected to buy a large stake in Healthcare Global Enterprises, which could make it the largest shareholder and a co-promoter of the Bengaluru-based cancer-care chain four years after its IPO, people in...
Alexion bets on Portola’s bleeding antidote with $1.41 billion deal
Alexion Pharmaceuticals Inc on Tuesday agreed to buy Portola Pharmaceuticals Inc in a $1.41 billion deal, as it looks to exploit smaller rival’s blood-thinning antidote which has reached only a tiny portion of its...
AbbVie wins U.S. antitrust approval to buy Allergan
Drugmaker AbbVie Inc has won U.S. antitrust approval to buy Botox maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies said on Tuesday. AbbVie, which has been under pressure to...
KKR likely to pick 20% stake in Piramal Enterprises for Rs 3,500 crore
Piramal Enterprises is close to selling up to 20 per cent in its pharmaceuticals business, and is scouting for buyers to take up the entire stake in Shriram group entities, as part of its efforts to cut debt and prepare...
AmerisourceBergen eyes Walgreens’ drug distribution business – sources
AmerisourceBergen Corp, one of the largest U.S. drug distributors, has approached Walgreens Boots Alliance Inc to explore a deal for its pharmaceutical wholesaling division, people familiar with the matter said on...
